140 related articles for article (PubMed ID: 27450161)
1. [Cytomegalovirus infection in adults. Must it be treated?].
Castón JJ; Torre-Cisneros J
Med Clin (Barc); 2016 Oct; 147(8):345-347. PubMed ID: 27450161
[No Abstract] [Full Text] [Related]
2. Immune-based monitoring for cytomegalovirus infection in solid organ transplantation: is it ready for clinical primetime?
Melendez D; Razonable RR
Expert Rev Clin Immunol; 2014 Sep; 10(9):1213-27. PubMed ID: 25081073
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus antigenemia as a marker for antiviral therapy after heart transplantation.
Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayr T; Prenner G; Hipmair G; Grasser B; Freigassner M
J Heart Lung Transplant; 1996 Mar; 15(3):314-5. PubMed ID: 8777216
[No Abstract] [Full Text] [Related]
4. Editorial commentary: Use of valganciclovir for prevention and treatment of cytomegalovirus disease.
Snydman DR
Clin Infect Dis; 2008 Jan; 46(1):28-9. PubMed ID: 18171209
[No Abstract] [Full Text] [Related]
5. Look and ye shall find...cytomegalovirus infection in immunocompetent patients.
Arend SM; Kroes AC
Clin Infect Dis; 2003 Dec; 37(12):1607-8. PubMed ID: 14689340
[No Abstract] [Full Text] [Related]
6. Cytomegalovirus disease after liver transplantation: diagnostics and therapy.
Wiens M; Schmidt CA; Lohmann R; Oettle H; Blumhardt G; Neuhaus P
Transplant Proc; 1993 Aug; 25(4):2673-4. PubMed ID: 8395108
[No Abstract] [Full Text] [Related]
7. Potential role of CC chemokine receptor 6 in prediction of late-onset cytomegalovirus infection following solid organ transplant.
Camargo JF; Resende MR; Zamel R; Klement W; Bhimji A; Huibner S; Kumar D; Humar A; Jurisica I; Keshavjee S; Kaul R; Husain S
Clin Transplant; 2015 Jun; 29(6):492-8. PubMed ID: 25690781
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of cytomegalovirus infection after stem-cell transplantation: a new option?
Einsele H; Hamprecht K
Lancet; 2003 Oct; 362(9393):1343-4. PubMed ID: 14585632
[No Abstract] [Full Text] [Related]
9. Cytomegalovirus infection in organ transplant recipients.
Hibberd PL; Snydman DR
Infect Dis Clin North Am; 1995 Dec; 9(4):863-77. PubMed ID: 8747770
[TBL] [Abstract][Full Text] [Related]
10. Immunologic predictors of late cytomegalovirus disease after solid organ transplantation--an elusive goal?
Boeckh M; Riddell SR
J Infect Dis; 2007 Mar; 195(5):615-7. PubMed ID: 17262699
[No Abstract] [Full Text] [Related]
11. Infection in solid-organ transplant recipients.
Fishman JA
N Engl J Med; 2007 Dec; 357(25):2601-14. PubMed ID: 18094380
[No Abstract] [Full Text] [Related]
12. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments.
Gandhi MK; Khanna R
Lancet Infect Dis; 2004 Dec; 4(12):725-38. PubMed ID: 15567122
[TBL] [Abstract][Full Text] [Related]
13. Significance of qualitative polymerase chain reaction combined with quantitation of viral load in the diagnosis and follow-up of cytomegalovirus infection after solid-organ transplantation.
Vanpoucke H; Van Vlem B; Vanholder R; Van Renterghem L
Intervirology; 1999; 42(5-6):398-404. PubMed ID: 10702723
[TBL] [Abstract][Full Text] [Related]
14. A cytomegalovirus vaccine for transplantation: are we closer?
Go V; Pollard RB
J Infect Dis; 2008 Jun; 197(12):1631-3. PubMed ID: 18444884
[No Abstract] [Full Text] [Related]
15. Treatment of cytomegalovirus infections in renal transplant recipients with 9-(1,3-dihydroxy-2-propoxymethyl) guanine.
Cantarovich M; Hiesse C; Lantz O; Fassi-Fihri S; Charpentier B; Fries D
Transplantation; 1988 Jun; 45(6):1139-41. PubMed ID: 2837848
[No Abstract] [Full Text] [Related]
16. Tolerance and efficacy of ganciclovir in the treatment of cytomegalovirus infections in immunosuppressed patients.
Ho WG; Winston DJ; Champlin RE
Transplant Proc; 1989 Feb; 21(1 Pt 3):3103-6. PubMed ID: 2539690
[No Abstract] [Full Text] [Related]
17. Thrombosis associated with acute cytomegalovirus infection: a meta-analysis.
Justo D; Finn T; Atzmony L; Guy N; Steinvil A
Eur J Intern Med; 2011 Apr; 22(2):195-9. PubMed ID: 21402253
[TBL] [Abstract][Full Text] [Related]
18. [Current treatment modalities of immunocompromised patients with cytomegalovirus infection. I. Epidemiological and clinical perspectives].
Sinkó J
Orv Hetil; 2019 Jan; 160(3):83-92. PubMed ID: 30640526
[TBL] [Abstract][Full Text] [Related]
19. [Cytomegalovirus-associated haemophagocytic syndrome in a kidney transplant patient].
Bea Granell S; Beneyto Castello I; Ramos Escorihuela D; Sánchez Plumed J; Sánchez Pérez P; Hernández-Jaras J; Rivas S
Nefrologia; 2011; 31(2):236-8. PubMed ID: 21461026
[No Abstract] [Full Text] [Related]
20. Ganciclovir treatment of systemic cytomegalovirus in an immunocompetent host.
Leman JS; Toalson TW; Wlodaver CG
J Okla State Med Assoc; 1997; 90(7):367-9. PubMed ID: 9379249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
